References
- Robins LN, Helzer JE, Weissman MM, et al. Lifetime prevalence of specific psychiatric disorders in three sites. Arch Gen Psychiatry 1984: 41 (10): 949–58
- Rifkin A. Depression: management rips for the primary care physician. Postgrad Med 1988: 83(2): 111–8
- Miles CR. Conditions predisposing to suicide: a review. J Nerv Ment Dis 1977: 164: 231–46
- Gorman JM, Fyer AF, Glicklich J, et al. Mitral valve prolapse and panic disorders: effect of imipramine. In: Klein DF, Rabkin JG, eds. Anxiety: new research and changing concepts. American Psychopathological Association series. New York: Raven Press, 1981: 317–40
- Ballenger JC, Burrows GD, DuPont RL Jr, et al. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment. Arch Gen Psychiatry 1988: 45(5): 413–22
- Rickels K, Schweizer EE. Current pharmacotherapy of anxiety and panic. In: Meltzer HY, ed. Psychopharmacology: the third generation of progress. New York: Raven Press, 1987: 1193–1203
- Sanderson WC, Rapee RM, Barlow DH. The influence of an illusion of control on panic attacks induced via inhalation of 5.5% carbon dioxide-enriched air. Arch Gen Psychiatry 1989: 46(2): 157–62